Form 8-K - Current report:
SEC Accession No. 0001125345-23-000113
Filing Date
2023-09-22
Accepted
2023-09-22 16:42:19
Documents
12
Period of Report
2023-09-19
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20230919.htm   iXBRL 8-K 28270
  Complete submission text file 0001125345-23-000113.txt   154489

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20230919.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20230919_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20230919_pre.xml EX-101.PRE 12708
6 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20230919_htm.xml XML 2717
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 231272219
SIC: 2834 Pharmaceutical Preparations